A detailed history of Frazier Financial Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 1 shares of OGN stock, worth $18. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 8 87.5%
Holding current value
$18
Previous $151,000 86.09%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $122 - $153
-7 Reduced 87.5%
1 $21,000
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $87 - $138
8 New
8 $116,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.65B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.